Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Insulin‐like growth factor 2 (IGF2) was recently found to play a critical role in memory consolidation in rats and mice, and hippocampal or systemic administration of recombinant IGF 2 enhances memory. Here, using a gene therapy‐based approach with adeno‐associated virus ( AAV ), we show that IGF 2 overexpression in the hippocampus of aged wild‐type mice enhances memory and promotes dendritic spine formation. Furthermore, we report that IGF 2 expression decreases in the hippocampus of patients with Alzheimer's disease, and this leads us to hypothesize that increased IGF 2 levels may be beneficial for treating the disease. Thus, we used the AAV system to deliver IGF 2 or IGF 1 into the hippocampus of the APP mouse model T g2576 and demonstrate that IGF 2 and insulin‐like growth factor 1 (IGF1) rescue behavioural deficits, promote dendritic spine formation and restore normal hippocampal excitatory synaptic transmission. The brains of T g2576 mice that overexpress IGF 2 but not IGF 1 also show a significant reduction in amyloid levels. This reduction probably occurs through an interaction with the IGF 2 receptor (IGF2R). Hence, IGF 2 and, to a lesser extent, IGF 1 may be effective treatments for Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 2×
“Hippocampal neurons interact extensively with neurons in the entorhinal cortex (EC), a brain area that shows early signs of AD pathology and abundant amyloid plaques (Gomez-Isla et al , 1996).”
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · cited 1×
“Previous studies have reported controversial results concerning the levels of IGF2 mRNA transcripts in the AD hippocampus compared to controls (Stein & Johnson, 2002; Stein et al , 2004; Steen et al , 2005).”
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“Furthermore, several studies show that the accumulation of soluble forms of Ab correlates with synapse dysfunction and loss (Shankar et al, 2007), which appears to occur relatively early in the disease, prior to cell death.”
BackgroundMegı́as, M., Emri, Z., Freund, T. F., & Gulyás, A. I. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00496-6 · Cited by 950
Rampon, C., Tang, Y.-P., Goodhouse, J., Shimizu, E., Kyin, M., & Tsien, J. Z. (2000) · Nature Neuroscience · doi:10.1038/72945 · Cited by 755
Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · cited 1×
“In line with previous findings (Rivera et al , 2005), we observed that IGF2 protein levels decline in the hippocampus of the AD brain; this led us to test the hypothesis that IGF2 is a potential treatment for AD in preclinical models.”
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
D'Amelio, M., Cavallucci, V., Middei, S., Marchetti, C., Pacioni, S., Ferri, A., Diamantini, A., De Zio, D., Carrara, P., Battistini, L., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2709 · Cited by 572
Cited by
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 375
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
Hocquemiller, M., Giersch, L., Audrain, M., Parker, S., & Cartier, N. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.087 · Cited by 291
“IGF-2 expression enhanced memory, promoted dendritic spine formation in wild-type mice, decreased amyloid levels, and rescued behavioral deficits in AD mice, suggesting that IGF-2 may act as an Ab scavenger.(81) Increasing evidence demonstrates the role of inflammation in AD.”
BackgroundShort, A. K., Fennell, K. A., Perreau, V. M., Fox, A., O’Bryan, M. K., Kim, J. H., Bredy, T. W., Pang, T. Y., & Hannan, A. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.109 · Cited by 230
Kamphuis, W., Kooijman, L., Schetters, S., Orre, M., & Hol, E. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.007 · Cited by 209
Viral vectors for therapy of neurologic diseases
Choudhury, S. R., Hudry, E., Maguire, C. A., Sena-Esteves, M., Breakefield, X. O., & Grandi, P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.013 · Cited by 190
“…neurons survive toxic injury, including delivery of cerebral dopamine neurotrophic factor (CDNF) (Kemppainen et al., 2015), insulin growth factor (Pascual-Lucas et al., 2014), brainderived neurotrophic factor (BDNF; Nagahara et al., 2013) and nerve growth factor (NGF; Tuszynski et al., 2015) to…”
Background
Metadata
- Authors
- Pascual‐Lucas, M., Viana da Silva, S., Di Scala, M., Garcia‐Barroso, C., González‐Aseguinolaza, G., Mulle, C., Alberini, C. M., Cuadrado‐Tejedor, M., & Garcia‐Osta, A.
- Venue
- EMBO Molecular Medicine
- Published
- 2014-08-07
- Volume
- 6
- Issue
- 10
- Pages
- 1246-1262
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2104162860
- Cited by
- 145
- References
- 19
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. https://app.cochat.ai/papers/10.15252/emmm.201404228
- The paper
- Pascual‐Lucas, M., Viana da Silva, S., Di Scala, M., Garcia‐Barroso, C., González‐Aseguinolaza, G., Mulle, C., Alberini, C. M., Cuadrado‐Tejedor, M., & Garcia‐Osta, A. (2014). Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201404228
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.